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Soluble klotho, the shed ectodomain of the antiaging membrane
protein α-klotho, is a pleiotropic endocrine/paracrine factor with
no known receptors and poorly understood mechanism of action.
Soluble klotho down-regulates growth factor-driven PI3K signal-
ing, contributing to extension of lifespan, cardioprotection, and
tumor inhibition. Here we show that soluble klotho binds mem-
brane lipid rafts. Klotho binding to rafts alters lipid organization,
decreases membrane’s propensity to form large ordered domains
for endocytosis, and down-regulates raft-dependent PI3K/Akt sig-
naling. We identify α2-3-sialyllactose present in the glycan of
monosialogangliosides as targets of soluble klotho. α2-3-Sialyllac-
tose is a common motif of glycans. To explain why klotho prefer-
entially targets lipid rafts we show that clustering of gangliosides
in lipid rafts is important. In vivo, raft-dependent PI3K signaling is
up-regulated in klotho-deficient mouse hearts vs. wild-type hearts.
Our results identify ganglioside-enriched lipid rafts to be receptors
that mediate soluble klotho regulation of PI3K signaling. Targeting
sialic acids may be a general mechanism for pleiotropic actions of
soluble klotho.
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Mice homozygous for a severe hypomorphic α-klotho allelemanifest multiple aging-related phenotypes and die pre-
maturely at 2–3 mo after birth (1). α-Klotho is predominantly
expressed in renal tubules, parathyroid glands, and epithelial cells
of the choroids plexus, but not in myocardium. Overexpression of
α-klotho extends life span in mice, indicating that it is an aging-
suppression molecule (2). The full-length α-klotho protein is a
single-pass membrane protein with a large extracellular domain, a
membrane-spanning segment, and a short intracellular carboxyl
terminus (1). Membranous α-klotho associates with FGF recep-
tors to form coreceptors for the ligand FGF23, a bone-derived
circulating hormone that plays an important role in phosphate
homeostasis (3).
The ectodomain of α-klotho, ∼950 aa in length, is composed of
two internal repeats, KL1 and KL2, each sharing amino acid se-
quence homology to family-1 glycosidases (4). The ectodomain
(soluble klotho, sKL) is released into the systemic circulation,
urine, and cerebrospinal fluid and functions as a humoral factor
(2, 5). To date, more than 10 different functions of sKL have been
described (2, 6–9). sKL regulates ion transporters, antagonizes
Wnt and TGF-β1signaling to suppress cellular senescence, tissue
fibrosis, and cancer metastasis, and inhibits insulin and insulin-like
growth factor-1 (IGF1)-driven PI3K/Akt signaling contributing
to extension of lifespan in mice, cardioprotection, and inhibition
of tumor cell proliferation. A fundamental gap in the under-
standing of sKL’s mechanism of action is the lack of knowledge
of potential membrane receptor(s) that mediate cellular responses
to sKL.
Lipid rafts are highly dynamic, cholesterol- and sphingolipid-
rich membrane microdomains that compartmentalize cellular
processes such as signal transduction and membrane trafficking
(10). Lateral association of sphingolipids and cholesterol in the
outer leaflet driven by the preferential affinity of sphingolipids
toward one another and toward cholesterol governs the sponta-
neous formation of lipid rafts. Here, we show that sKL binds lipid
rafts and identify α2-3-sialyllactoses of monosialogangliosides,
GM1 and GM3, as targets. Klotho binding to lipid rafts alters lipid
organization and down-regulates raft-dependent PI3K signaling.
Sialyllactoses are common motifs of glycans present in many
glycoproteins as well as gangliosides (11). We further show
that clustering of gangliosides in lipid rafts enhances the affinity
for sKL and demonstrate that sKL preferentially targets raft-
associated gangliosides vs. isolated gangliosides in nonraft mem-
branes. To demonstrate the in vivo relevance, we show that lipid
raft-dependent PI3K/Akt signaling is up-regulated in hearts iso-
lated from klotho-deficient vs. wild-type mice. Our results reveal
sKL to be a physiological regulator of lipid raft formation and
function and provide a potential general mechanism for pleiotropic
actions of sKL.
Significance
Soluble klotho is the shed ectodomain of the antiaging mem-
brane protein α-klotho that exhibits pleiotropic actions, in-
cluding down-regulation of growth factor-driven PI3K signaling,
contributing to lifespan prolongation, cardioprotection, and tu-
mor inhibition. Whether membrane receptors exist for soluble
klotho is unknown. We identify lipid rafts as receptors for sol-
uble klotho. We show klotho binds specific sialic acid residues
of gangliosides highly enriched in the outer leaflet of lipid
rafts. Klotho binding to gangliosides modulates lipid organi-
zation and inhibits lipid raft-dependent PI3K signaling. In vivo,
klotho-deficient mouse hearts have heightened raft-dependent
PI3K signaling vs. wild-type hearts. We reveal a novel physio-
logical regulator of lipid raft structure and function, and open
new research to understand pleiotropic effects of klotho in cell
signaling and metabolism.
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Results
sKL Binds Lipid Rafts and Modulates Lipid Organization Within Rafts.
sKL is pleiotropic. We posit that multifunctional lipid rafts may
be receptors for sKL. sKL comigrated with markers of lipid rafts
(Fig. 1A), indicating affinity for isolated lipid rafts. To examine
whether klotho binds lipid rafts in intact cells and the potential
effects of binding, we used colocalization analysis of two differ-
ent fluorophore-labeled gangliosides in cell membranes. HeLa
cells were stained with CTxB-Alexa Fluor-594 conjugate (to label
endogenous GM1) followed by exogenous BODIPY-FL-C5-GM1
and imaged by dual-color confocal microscopy. Correlation be-
tween pixel intensity histogram of CTxB-labeled red channel and
BODIPY-GM1 green channel was analyzed by Pearson’s corre-
lation (coefficient values “1” and “0” correspond to perfect
colocalization and completely random uncorrelated distribution,
respectively). As shown, mean Pearson’s coefficient (p.c.) for
CTxB-labeled GM1 and BODIPY-GM1 is 0.53 ± 0.02 (Fig. 1 B
and C; P < 0.001 vs. 0), indicating highly significant colocaliza-
tion. Disrupting lipid rafts by methyl-β-cyclodextrin (MβCD)
markedly reduced p.c. for CTxB and BODIPY-GM1 to a value
not significantly different from 0, supporting that the two fluo-
rescence-labeled gangliosides are highly colocalized in lipid rafts
(Fig. 1B and Fig. S1A). Caveolin-1, a marker for lipid rafts, also
showed significant colocalization with CTxB, whereas the non-
raft protein CD71 (transferrin receptor) did not show colocali-
zation with CTxB (Fig. 1B and Fig. S1 B and C). Treatment with
sKL markedly decreased p.c. for CTxB and BODIPY-GM1 (Fig.
1B and Fig. S1D; see Fig. S1 legend for comments).
The resolution of confocal microscopy is limited by the diffrac-
tion of light to ∼250 nm. To support that klotho targets lipid rafts,
we conducted Förster resonance energy transfer (FRET) studies.
FRET detects molecular interactions on a scale of 1–10 nm,
smaller than the lowest size limit of rafts (10–200 nm). FRET was
measured by fluorescence lifetime imaging microscopy (FLIM) and
analyzed by the phasor approach (12). As a control, lifetime for
Fig. 1. Klotho binds lipid rafts and alters lipid organization. (A) Purified sKL was layered on top of HeLa cell lysates and fractioned by sucrose-density
gradient centrifugation. An equal volume from each fraction was acetone-precipitated and analyzed for klotho, caveolin-1, and protein-associated GM1.
(B) Cells were incubated with CTxB and BODIPY-GM1 at 4 °C to prevent endocytosis. Cells were treated with klotho (300 pM, 10 min) or MβCD (10 mM, 30 min)
at 37 °C before CTxB and BODIPY-GM1. Data are mean ± SEM (n = 10–17 images as indicated for each group). (C) Representative images and Pearson’s
correlation analysis of colocalization between CTxB and BODIPY-GM1. The scatterplot shows a 2D intensity histogram of the red and green pixels in the
image. Pixels with intensity above the thresholds (indicated for each channel by the white lines) are colocalized. Pearson’s correlation coefficient (R2) for the
colocalized volume = 0.591. (Scale bars, 5 μm.) (D) Cells were stained with BODIPY FL-505/510-C5-GM1 (donor) with or without CholEsteryl BODIPY 542/563-C11
(acceptor), excited with a two-photon laser at 900 nm, and emission was collected at 506–594 nm using FLIM. Merged intensity images (showing green
BODIPY-GM1 with some internalization) and pseudocolor lifetime images are shown. Experiments were performed four times with similar results. (Scale bars,
10 μm.) (E) Phasor plot of fluorescence lifetime histogram from cells stained with GM1 only (Top) and the trajectory of FRET between GM1 and cholesterol
(Bottom). Blue circle marks lifetime for donor only, purple circle for donor + acceptor, and green circle for background autofluorescence (from unstained
cells). Phasor plot analysis showed FRET efficiency ∼25%, with fractional contribution of lifetimes ∼51% from quenched donor, 44% from unquenched donor,
and 5% from background.











GM1 (donor) in the absence of cholesterol (acceptor) has longer
values, and sKL treatment did not affect lifetime for GM1 alone
(Fig. 1D, Top; blue color ≈ longer lifetime values). Lifetime for
GM1 shifted to the shorter values (purple) in the presence of
cholesterol, indicating quenching of GM1 by cholesterol (i.e.,
FRET occurrence between GM1 and cholesterol; Fig. 1D,
Middle). Klotho treatment decreased FRET between GM1 and
cholesterol – lifetime for GM1 shifted back to the longer values
(Fig. 1D, Bottom). Phasor plot analysis supported the validity of
FLIM-FRET data (Fig. 1E). The results indicate that klotho
treatment decreased FLIM-FRET occurrences between GM1
and cholesterol, supporting an effect of klotho binding on lipid
organization within rafts. Lipid rafts feature a high degree of
membrane order. sKL decreases membrane order (SI Text and
Fig. S2), further supporting that it binds lipid rafts to modulate
lipid organization.
Klotho Selectively Down-Regulates Lipid Raft-Dependent PI3K/Akt
Signaling and Thereby Inhibits TRPC6 Channel Function. sKL inhibits
growth factor (GF)-driven PI3K signaling (2, 9). PI3K is present in
lipid rafts and in nonraft membranes depending on context (13).
Supporting that lipid rafts are receptors for sKL and mediate its
effect to inhibit PI3K signaling, sKL treatment down-regulated
PI3K/Akt signaling associated with lipid rafts (fractions 4 and 5,
marked by caveolin-1), but not in nonraft regions (fractions 9–12;
Fig. 2 A and B). The specificity of sKL on lipid raft-dependent,
GF-driven PI3K/Akt signaling is further evidenced by findings that
whereas IGF1 restored PI3K/Akt signaling in raft and nonraft
regions after its down-regulation by serum starvation, klotho
treatment only affected IGF1-stimulated PI3K/Akt signaling in
the rafts (Fig. S3). For comparison, pharmacological inhibition of
PI3K by wortmannin (Wmn) abrogated PI3K/Akt signaling in
both raft and nonraft regions (Fig. S3; see legend for comments).
sKL inhibits PI3K-dependent diacylglycerol (DAG)-stimulated
exocytosis of TRPC6 channels, underlying its cardioprotective
action (9). TRPC6 channel is activated by DAG via dual mecha-
nisms: (i) direct activation of channel gating and (ii) stimulation of
channel exocytosis (Fig. 3A and refs. 14 and 15). We used DAG-
stimulated TRPC6 function as an additional experimental system
to study the regulation of PI3K signaling by sKL. As reported
before, klotho inhibited DAG-stimulated TRPC6 currents, an
effect not additive to the effect of Wmn or to tetanus toxin (TTX)-
mediated blocking of channel exocytosis (Fig. 3B). Because klotho
down-regulates PI3K signaling to inhibit DAG-stimulated TRPC6
exocytosis but does not affect direct channel gating by DAG, the
maximal inhibition of TRPC6 by klotho is only partial (Fig. 3 A
and B). Treatment with the cholesterol binder filipin decreased
DAG-stimulated TRPC6 currents and prevented further in-
hibition of currents by klotho (Fig. 3C). There was no additivity
among inhibition of TRPC6 caused by klotho, filipin, TTX, and
Wmn (Fig. 3C, Inset and Fig. S4). Thus, lipid rafts mediate down-
regulation of PI3K-dependent TRPC6 exocytosis by sKL. In-
hibition of TRPC6 by klotho was reversed after klotho washout
(Fig. S5).
Sphingolipids including gangliosides are important compo-
nents of lipid rafts. Pretreatment of cells with N-butyldeox-
ygalactonojirimycin (NB-DGJ), which blocks biosynthesis of
gangliosides (16), decreased DAG-stimulated TRPC6 currents
and prevented further decreases by sKL (Fig. 3 D and E).
Specificity of NB-DGJ–mediated depletion of membrane gan-
gliosides is supported by findings that application of exogenous
GM1, but not asialo-GM1 (a GM1 analog missing sialic acid),
reversed NB-DGJ–induced decreases of TRPC6 currents to the
control level without NB-DGJ (Fig. 3E). In cells rescued from
the effect of NB-DGJ by GM1, klotho treatment decreased
TRPC6 currents. GM3 is a more abundant monosialoganglioside
than GM1 in many nonneuronal tissues (17). Thus, we examined
the role of GM3. Exogenous GM3, but not lactosylceramide
(LacCer; a GM3 analog missing sialic acid), also reversed the
inhibition of TRPC6 caused by NB-DGJ and restored the effect
of klotho to inhibit TRPC6 after NB-DGJ (Fig. 3F). Thus, gan-
gliosides and cholesterol-enriched lipid rafts mediate klotho
regulation of PI3K signaling and TRPC6 function.
Klotho Specifically Targets α2-3-Sialyllactose in the Glycan of
Gangliosides to Regulate Lipid Rafts. Lipid rafts also contain gly-
coproteins with α2-3-sialic acid in the glycan structure. We next
address whether sKL targets α2-3-sialic acids present in ganglio-
sides or in raft-associated glycoproteins to regulate TRPC6
function, by using disialoganglioside GD3 that has an additional
α2-8-sialic acid linkage to the underlying α2-3-sialic acid (Fig.
3D). Exogenous GD3 rescued PI3K-dependent TRPC6 activity
after inhibition by NB-DGJ (Fig. 3G), indicating it can substitute
endogenous gangliosides for klotho regulation of TRPC6. In-
terestingly, klotho treatment failed to inhibit TRPC6 in cells
rescued by GD3 after NB-DGJ. The fact that whereas both GD3
and GM3 rescue TRPC6 currents klotho only inhibited TRPC6 in
cells rescued by GM3, but not by GD3, indicates that klotho
targets exposed α2-3–linked sialic acid in gangliosides, rather than
α2-8–linked sialic acid. Because glycoproteins in lipid rafts are not
expected to be different in GD3-rescued vs. GM3-rescued cells,
the results argue against klotho’s targeting α2-3-sialic acid–
containing glycoproteins.
This notion is further extended by competition experiments.
When preincubated with GM1, but not asialo-GM1, klotho
failed to inhibit TRPC6 (Fig. S6A). Moreover, preincubation
with GM3, but neither LacCer nor GD3, neutralized the ability
of klotho to inhibit TRPC6 (Fig. S6 A–C). Inability of GD3 to
neutralize the effect of klotho lends additional support to the
Fig. 2. Klotho inhibits lipid raft-associated PI3K signaling. (A and B) HeLa
cells in serum-containing medium were treated with sKL before lysis in an
ice-cold detergent lysis buffer containing 1% Triton X-100 and subjected to
sucrose gradient ultracentrifugation. pT-Akt, phosphorylation of Akt at Thr-
308; pS-Akt, at Ser-473. T-Akt indicates total Akt. A shows one representa-
tive experiment. B shows mean ± SEM from four separate experiments.
Intensity values were determined from densitometry. Ratios of phospho-Akt
over total Akt (pT-Akt/T-Akt, pS-Akt/T-Akt) are also shown. *P < 0.01, sKL vs.
vehicle.
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finding in Fig. 3G that accessibility of α2-3–linked sialic acid is
critical for klotho binding. Together, the results in Fig. 3G and
Fig. S6 A–C point to the structure of GM3 glycan, α2-3-sialyllactose
(Neu5Acα2-3Galβ1-4Glc; also known as 3′-sialyllactose), as the
minimal motif for klotho binding and regulation of TRPC6. In-
deed, 3′-sialyllactose at a concentration (3 mM) much higher
than that for GM1 and GM3 in the above experiments (10 μM)
fully neutralized the effect of klotho, whereas lactose at the same
concentration had no effect (Fig. S6D). The apparent Kd for
GM3 binding to klotho, based on IC50 for competing klotho
inhibition of TRPC6, is ∼3 μM (Fig. S6E). The apparent Kd
determined similarly for 3′-sialyllactose binding to klotho is ∼1 mM
(Fig. S6F) and agrees with the Kd for 3′-sialyllactose binding with
sialic acid-binding Ig-like lectin (Siglec) family proteins (18). GM3
forms micelles in solution, likely explaining differences in the ap-
parent Kd for GM3 vs. free 3′-sialyllactose (Discussion). α2-
6-Sialyllactose (Neu5Acα2–6Galβ1-4Glc; also known as 6′-
sialyllactose) also competed for klotho’s effect although with slightly
less efficacy than 3′-sialyllactose (Fig. S7). Next, we used biolayer
interferometry to analyze binding of klotho to 3′-sialyllactose in
vitro. Klotho bound to streptavidin-immobilized biotin-labeled
3′-sialyllactose, but not to lactose (Fig. S6 G and H). Kd for the
Fig. 3. Klotho inhibits PI3K-dependent DAG-stimulated exocytosis of TRPC6. (A) Diagram illustrating dual effects of DAG on TRPC6. (B) Inset shows current-
voltage (I-V) relationship for DAG-stimulated currents. OAG (a membrane-permeant analog of DAG, 100 μM) was used to activate TRPC6. Data are mean ±
SEM of maximal DAG-stimulated inward TRPC6 current density (Δ current ± DAG in pA at −100 mV divided by cell capacitance in picofarads). *P < 0.01 vs.
control (first bar from left). n = 8–12 each group. sKL (300 pM for 3 h); Wmn (200 nM for 20 min); TTX (50 nM for 3 h). (C) No additivity among inhibition of
TRPC6 by sKL, filipin (2 μg/mL for 1 h), TTX, and Wmn. *P < 0.01 vs. control (first bar from left). n = 9–12 each group. (D) Diagram for metabolic pathway of
some gangliosides pertinent in this study. NB-DGJ blocks glucosylation of ceramide, the entry step of ceramide biosynthesis into gangliosides. (E) Cells were
treated with NB-DGJ (25 μM) for 7 h, then together with exogenous GM1 or asialo-GM1 (10 μM each) for additional 19 h. After removing medium containing
both, cells were treated with sKL in a new medium for 3 h before recording. n = 10–13 each group. *P < 0.01 between indicated groups. #P < 0.01 vs. control
(first bar from left). (F) Experiment as in E except exogenous GM3 or LacCer (10 μM each) was used. n = 12–14 each group. *P < 0.01 between indicated
groups. #P < 0.01 vs. control (first bar from left). (G) Experiment as in E except exogenous GD3 (10 μM) was used. n = 10–13 each group. *P < 0.01 between
indicated groups. NS, not significant.











binding is estimated ∼40 nM. High density of 3′-sialyllactose
immobilized on the binding surface likely explains the apparently
higher binding affinity of klotho determined by this method.
Klotho Binds Lipid Rafts in Live Cells by Interacting with Raft-
Associated GM1. To further support that klotho indeed binds to
monosialogangliosides clustered in lipid rafts, we examined
klotho interaction with GM1 in live cells by studying FRET be-
tween fluorophore-labeled klotho and BODIPY-GM1. Addition
of fluorophore-labeled klotho causes fluorescence quenching
of cell membrane BODIPY-GM1 analyzed by FLIM-FRET in
10 min (Fig. 4 A and B), indicating klotho and GM1 interact
within a 10-nm distance. In cells pretreated with MβCD to disrupt
lipid rafts, BODIPY-GM1 remained partitioned into cell mem-
branes, but addition of fluorophore-labeled klotho failed to
quench GM1 fluorescence (Fig. 4 C and D). As a control, addition
of unlabeled klotho to normal cells did not cause quenching of
BODIPY-GM1 (Fig. 4E). The results provide direct evidence to
support that klotho targets raft-associated GM1. In addition,
klotho prevents cells from forming large ordered domains but
does not cause global membrane disorder (SI Text and Fig. S8).
Evidence for Effect of sKL on Lipid Rafts in Vivo.Cardioprotection by
klotho is mediated by circulating sKL through down-regulating
PI3K-dependent activation of TRPC6 channels (9). To in-
vestigate the role of klotho on lipid rafts in vivo, we first showed
that lipid rafts mediate sKL’s effect to down-regulate PI3K-
dependent TRPC6 channel function in freshly isolated cardiac
myocytes: Filipin, Wmn, and klotho each decreased TRPC6-
mediated currents by a similar degree, and the combined effects
from individual agents were not additive (Fig. 5A). Together with
the recent report that TRPC6 is localized to lipid rafts of isolated
myocytes (19), the results support that raft-dependent PI3K
signaling in the heart is a useful readout for in vivo effects of sKL
on lipid rafts. We then compared raft-associated PI3K signaling
in klotho-deficient hearts vs. wild-type hearts. Raft-dependent
PI3K signaling was significantly up-regulated in klotho-deficient
hearts (from mice rescued from death by dietary phosphate re-
striction) compared with wild-type hearts (Fig. 5 B and C). The
increase in PI3K signaling was restricted to lipid rafts; no dif-
ferences in PI3K signaling were observed in nonraft membranes
between klotho-deficient and wild-type hearts. Thus, circulating
sKL plays an important role in regulating lipid rafts in vivo.
Discussion
Monosialogangliosides are dynamically distributed between raft
and nonraft membranes as lipid rafts undergo self-assembly
and disassembly. sKL normally circulates at very low levels (30–
100 pM) (2). The low affinity of sKL for α2-3-sialyllactose (Kd
∼1 mM) suggests that isolated α2-3-sialyllactose monomers in
nonraft membranes may not be effective physiological targets of
sKL. Glycan clustering is a common mechanism for enhancing
binding of low-affinity glycans to multivalent glycan-binding
proteins (11). sKL is likely multivalent due to the fact that sKL
forms dimers and each unit contains two highly homologous KL1
and KL2 domains with potential glycan-binding activity (4, 20).
Results of in vitro binding assays and competition experiments
using TRPC6-based functional assays show that the apparent
Fig. 4. Klotho–GM1 interaction live cell membranes analyzed by FLIM-FRET.
(A) HEK cells were stained with BODIPY FL-505/510-C5-GM1 (donor; 100 nM).
Lifetime for GM1 alone has longer values (blue color cursor ≈ regions with
longer lifetime values). Lifetime for GM1 shifted to the shorter values
(purple color cursor) in the presence of fluorophore-labeled sKL (acceptor;
300 pM) over 10 min, indicating quenching of GM1 by sKL and FLIM-FRET
occurrence between GM1 and klotho. (B) Phasor plot analysis of FLIM-FRET
data showed FRET efficiency ∼20%, with fractional contribution of lifetimes
∼36% from quenched donor, 55% from unquenched donor, and 9% from
background. In the trajectory, blue circle marks lifetime for donor plus un-
labeled klotho, purple circle for donor plus labeled klotho, and green circle
for background autofluorescence. (C and D) Cells were pretreated with
5 mMMβCD for 3 h at 37 °C to disrupt lipid rafts. GM1 lifetime after addition
of fluorophore-labeled sKL was comparable to GM1 only, indicating little
to no FRET occurrence between GM1 and klotho. Shown is representative
of three separate experiments with similar findings. (E) Addition of un-
labeled klotho does not cause shift to shorter values (vs. A), indicating no
quenching of BODIPY-GM1 fluorescence by unlabeled klotho. (Scale bars,
5 μm in A, C, and E.)
Fig. 5. Evidence for klotho down-regulation of lipid raft-associated PI3K
signaling in vivo. (A) DAG-stimulated TRPC6 currents were recorded in
ventricular myocytes isolated from mice after isoproterenol overstimulation
to induce TRPC6 surface expression (9). Data are mean ± SEM of inward
current density. n = 10–13 each group. *P < 0.01 vs. control (first bar from
left). (B and C) Raft-associated PI3K/Akt signaling (marked by caveolin-3) is
up-regulated in klotho-deficient mouse hearts vs. wild-type mouse hearts.
Hearts isolated from wild-type or homozygous klotho knockout mice were
homogenized, lysed in ice-cold 1% Triton X-100 buffer, and subjected to
sucrose gradient ultracentrifugation. B shows one representative experi-
ment. C shows mean ± SEM from four separate experiments. *P < 0.01, wild-
type vs. klotho-deficient hearts.
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binding affinity of sKL for clustered α2-3-sialyllactoses is >300-
fold higher than for free α2-3-sialyllactoses, strongly supporting
the notion that lipid rafts highly enriched in α2-3-sialyllactose–
containing gangliosides are effective physiological targets of sKL.
The notion of selective targeting of sKL to lipid rafts is further
supported by FRET experiments in live cells showing that klotho
selectively interacts with raft-associated GM1, and by experi-
ments using the highly sensitive electric probe C6TPP showing
that sKL does not affect disordered membranes that reflect
nonraft membrane regions (Fig. S8). Moreover, raft-dependent
PI3K signaling is selectively up-regulated in klotho-deficient
hearts compared with wild-type hearts. The precise stoichiome-
try of klotho subunits and sialyllactose motifs required for ef-
fective binding in vivo remains to be determined.
Local lipid and protein interactions and interactions of raft
proteins or lipids with cortical actin cytoskeleton play important
roles in lipid raft formation (10, 21). Physiological soluble factors
that control the formation and function of lipid rafts are much less
known. We identify sKL as a physiological circulating regulator of
lipid rafts by targeting sialogangliosides. Physiological levels of sKL
likely modulate the function of lipid rafts acting as a rheostat rather
than as an on–off switch. Interestingly, a recent paper reports that
soluble FLT1 (the shed ectodomain of VEGF receptors) also
regulates podocyte function by binding to GM3 in lipid rafts (22).
We have also found that klotho is expressed in podocytes and
protects podocytes against injury (23). Thus, gangliosides-enriched
lipid rafts are important targets of extracellular factors with po-
tentially important biological and disease significance.
sKL is a pleiotropic hormone with poorly understood mech-
anism of action (2, 6–9). Lipid rafts may mediate multiple cel-
lular effects of sKL. The physiological effect of klotho through
targeting sialic acid, however, is not limited to glycolipids. Pre-
viously, we showed that sKL targets terminally exposed α2-6-
sialic acids in the N-glycan of TRPV5 to prevent its endocytosis
via caveolae (24). Here, we show that α2-3-sialyllactose also
binds klotho, supporting that klotho targets both α2-3– and α2-6–
linked sialic acids. Klotho’s effect on N-glycans of TRPV5 is
different from that on lipid rafts. Klotho’s effect on lipid rafts is
reversible on washout. Further, the effect of klotho on TRPC6
function is mediated by raft-dependent PI3K/Akt signaling,
whereas klotho acts directly on the TRPV5 channel protein (9,
24, 25). Regarding klotho’s effect on α2-6-sialyllactose of TRPV5
N-glycans, the binding affinity may be enhanced by the channel’s
tetrameric structure and concentration in caveolae. Ultimately,
the crystal structure of klotho will help elucidate the molecular
basis of klotho’s specificity for α2-3- and α2-6-sialic acid and the
role of underlying lactose.
In summary, sialic acids in the context of α2-3- or α2-6-sial-
lylactose are low-affinity targets of sKL. Through enrichment of
gangliosides containing terminal α2-3-sialyllactoses, lipid rafts
form effective binding sites for physiologically low circulating
levels of sKL. sKL binding to lipid rafts modulates lipid orga-
nization and down-regulates PI3K signaling, perhaps by affecting
function of raft-associated GF receptors and/or recruitment of
PI3K to rafts or its activity.
Materials and Methods
Expanded methods are available in SI Materials and Methods. Animal use
was approved by the institutional animal care and use committee of the
University of Texas Southwestern Medical Center.
Lipid rafts were fractioned by sucrose gradient ultracentrifugation. Con-
focal imaging of fluorophore-labeled CTxB, GM1, cholesterol, and FLIM-FRET
studies were performed using a Zeiss LSM510 laser scanning confocal mi-
croscope system. GP studies were performed by staining cells with Di-4-
ANEPPDHQ. Binding studies were performed using biolayer interferometry.
Whole-cell patch-clamp recording was performed in HEK or HeLa cells
transfected with TRPC6 plasmid.
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SI Text
Klotho Decreases Membrane Order Analyzed by Generalized Polarization.
The biophysical hallmark of lipid rafts is a high degree of membrane
order. We examined the effect of klotho onmembrane order using a
polarity-sensitive membrane probe that undergoes an emission
spectral shift when residing in the liquid-ordered vs. disordered
phase (26). Generalized polarization (GP), the ratio of fluorescence
intensity recorded in two spec-tral channels, becomes increasingly
more negative within 5–10 min of klotho treatment, indicating de-
creasing membrane order (Fig. S2 A and B). The effect of klotho on
GP is reversible after klotho washout (Fig. S2C). Together, the
above results provide compelling support for the notion that klotho
binds to lipid rafts and that binding modulates lipid organization
within rafts.
Klotho Prevents Cells from Forming Large Ordered Domains but Does
Not Cause Global Membrane Disorder. Large intracellular Ca2+
transients cause massive endocytosis (MEND) in many cell types
by inducing coalescence of ordered membrane domains (27).
Supporting that klotho binding to gangliosides hinders mem-
brane ordering, klotho treatment strongly reduced MEND in
HEK293 cells expressing Na+/Ca2+ exchangers that are used to
generate Ca2+ transients (Fig. S8 A and B). Pretreatment with
NB-DGJ prevented the effect of sKL to reduce MEND, further
supporting the notion that the effect of klotho is due to binding
to gangliosides.
To test further whether klotho binding causes global membrane
disorder, we used an electrogenic membrane probe hexyl-
triphenylphosphonium (C6TPP) that preferentially translocates
across the disordered membrane (28). Transmembrane current
carried by C6TPP is strongly increased by extracting cholesterol
from cells with cyclodextrins (27). As shown, the inward currents
generated by external application of C6TPP at three different
concentrations in HEK293 cells were unaffected by klotho treat-
ment (Fig. S8 C and D). Thus, the effects of klotho are specific to
a subset of membrane subdomains (i.e., lipid rafts) in the resting
state of cells. The fact that sKL is selective for lipid rafts and does
not cause global membrane disorder is consistent with its being a
physiological regulator of cell membrane function.
Besides down-regulation of raft-dependent PI3K signaling,
klotho treatment also markedly reducesMEND triggered by large
Ca2+ influx. Both effects of sKL are mediated by klotho binding
to gangliosides, because they are prevented by depletion of
gangliosides. Depletion of gangliosides by NB-DGJ treatment,
however, does not affect MEND in itself. MEND is believed to
occur as a result of large coalescence of ordered domains leading
to phase separation in cell membranes (27). NB-DGJ depletes
gangliosides but does not affect the biosynthesis of ceramide and
sphingomyelin (Fig. 3D). Ceramide and sphingomyelin can
support the formation of lipid rafts (10, 28), explaining why
MEND is not affected by NB-DGJ. These results lend further
support for structural and functional heterogeneities of ordered
membrane microdomains and for the idea that sKL targets to
monosialoganglioside-enriched membrane subdomains.
SI Materials and Methods
Materials.MβCD was from Sigma-Aldrich. IGF1 and recombinant
human klotho protein were from R & D Systems. Cholera toxin
subunit B-Alexa Fluor 594 conjugate, FITC-goat anti-rabbit IgG
(H+L) secondary antibody, BODIPY FL C5-ganglioside GM1,
CholEsteryl 4,4-difluoro-5-(4-methoxyphenyl)-4-bora-3a,4a-diaza-
s-indacene-3-undecanoate, and Di-4-ANEPPDHQ were from
ThermoFisher Scientific. Anti-cholera toxin B subunit (B040M)
was from GeneTex, Inc. Anti-Akt1/PKBα (AW24), Wmn, and
protease inhibitor mixture set III were from EMD Millipore.
Anti–caveolin-3 was from Novus Biologicals. Anti-klotho (KM2076)
was from TransGenic, Inc. Anti–phospho-Akt (Ser473 and Thr308)
were from Cell Signaling Technology. Anti–caveolin-1 (N-20),
anti-CD71 (H-300), and horseradish peroxidase conjugated second-
ary antibodies were from Santa Cruz Biotechnology. All phos-
phoinositides, BODIPY-C16 -PtdIns(4,5)P2, tetramethylrhodamine
(TMR)-C16-PtdIns(4,5)P2, and carriers (Histone H1) were from
Echelon Biosciences.
Isolation of Lipid Rafts from HeLa Cells and Mouse Heart by Sucrose
Gradient Ultracentrifugation.HeLa cells were maintained at 37 °C
under a 5% (vol/vol) CO2 atmosphere in DMEM (ThermoFisher
Scientific) supplemented with 100 units/mL penicillin and 100 μg/mL
streptomycin, 10% (vol/vol) FBS, and 1 mM sodium pyruvate
(Sigma-Aldrich). For cell preparation and isolation of lipid rafts
(29), HeLa cells were grown to confluence in two 100-mm culture
dishes. Cells were washed three times with ice-cold PBS (2.7 mM
KCl, 137 mM NaCl, 1.8 mM KH2PO4, and 10 mM Na2HPO4,
pH 7.4). Upon completion of the PBS wash, 2 mL of ice-cold
detergent lysis (DL) buffer (10 mM Tris·HCl, pH 7.4, 1 mM
EDTA, 0.5 mM EGTA, 250 μM Na orthovanadate, 1 mM Na
fluoride, 1% Triton X-100, and protease inhibitor mixture) was
added to one cell culture dish for 1 min on ice. After 1 min in DL
buffer, cell lysates were removed by scraping and were transferred
sequentially to the second dish for 1 min on ice. Cell lysates or
dissected mouse hearts (from klotho-deficient mice and wild-type
littermates) were transferred to a 2-mL loose-fitting Dounce ho-
mogenizer for 20 min on ice. Homogenization was then carried
out with 10 strokes of the homogenizer on ice. The homogenates
were transferred into the bottom of a 12-mL ultracentrifuge tube
and were adjusted to 40% (wt/vol) sucrose by addition of an
equal volume of 80% (wt/vol) sucrose in DL buffer. A discon-
tinuous sucrose gradient was generated by overlaying with 4 mL
of 30% (wt/vol) sucrose in DL buffer and 4 mL of 5% (wt/vol)
sucrose in DL buffer. The solution was then centrifuged at
210,000 × g for 20 h at 4 °C in an SW 41 Ti rotor (Beckman
Coulter). At completion of centrifugation, a faint light-scattering
band consisting of lipid raft/caveolar material was observed at the
5% sucrose–30% (wt/vol) sucrose interface. Twelve 1-mL fractions
were collected from the top of the tube. Aliquots of each fraction
were precipitated with prechilled acetone at −20 °C for 1 h. Pre-
cipitates were collected by centrifugation and pellets were washed
twice with acetone. The supernatant was removed and the re-
maining acetone was allowed to evaporate. Pellets were resus-
pended in 1× Laemmli’s sample buffer [62.5 mM Tris·HCl, pH 6.8,
2% SDS, 10% (vol/vol) glycerol, 0.002% bromophenol blue, and
100 mM DTT] and stored frozen until ready for analysis by SDS/
PAGE gel electrophoresis. For GM1 staining, each fraction was
dot-blotted on PVDF membranes and probed with cholera toxin
subunit B-Alexa Fluor 594 conjugate and anti-cholera toxin B
subunit antibodies. Dot blots were then incubated with secondary
antibodies conjugated to horseradish peroxidase for 1 h at room
temperature and visualized by enhanced chemiluminescence.
Immunofluorescence Staining, Imaging, and Image Analysis. HeLa
cells were allowed to adhere to poly-L-lysine–coated coverslips
overnight at 37 °C. Following treatment with klotho or MβCD
at 37 °C, cells were rinsed with ice-cold PBS three times and
incubated with 1 μg/mL cholera toxin subunit B-Alexa Fluor 594
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conjugate on ice for 20 min. For double immunofluorescence
staining of endogenous GM1 with exogenous GM1 ganglioside,
cells were rinsed with ice-cold PBS three times and incubated
with 50 nM BODIPY-FL-C5-GM1 on ice for 5 min. After
washing with ice-cold PBS, the cells were immediately fixed with
4% (wt/vol) paraformaldehyde (PFA) for 15 min at room tem-
perature. For double immunofluorescence staining of endogenous
GM1 ganglioside with caveolin-1 or CD71, cells were stained with
cholera toxin subunit B-Alexa Fluor 594 conjugate as described.
After fixation with 4% PFA, cells were rinsed with PBS, blocked,
and stained with anti–caveolin-1 (N-20) or anti-CD71 (H-300) for
1 h at room temperature. Following PBS washing steps, secondary
antibody staining was performed with FITC-conjugated goat anti-
rabbit IgG. Coverslips were then washed with PBS and mounted
in ProLong Gold antifade reagent (ThermoFisher Scientific).
Images were acquired and processed using a Zeiss LSM510 laser
scanning confocal microscope system with a Zeiss 63× oil-im-
mersion objective. Quantitative colocalization analysis of confocal
fluorescence microscopy images was carried out using ImageJ
software with the colocalization threshold plugin (30).
Biolayer Interferometry.Biolayer interferometry is a technology that
detects association of an analyte to a ligand that is immobilized to
an optical sensor. Association leads to a change in the interference
pattern of the light reflected from the end of the sensor, which is
translated directly into the thickness of the bound layer of analyte.
Biolayer interferometry was performed using the Octet Red384
system with ForteBio Octet analysis software (ForteBio). Mea-
surement buffer consisted of a 10/1 (vol/vol) mix of 1× kinetics
buffer (18-1092; Fortebio) with 50% (vol/vol) glycerol, 0.1 mM
EDTA, and 20 mM MES. In each measurement, streptavidin
sensors were uncoated in measurement buffer for 15 min,
loaded with 150 nM biotin, biotindiol, or biotinylated glycan for
4 min followed by incubation with fresh klotho solution at 30 °C
for 400 s and dissociation for 500 s. Biotindiol served as ref-
erence. The data were processed by subtraction of the signal for
biotindiol, alignment to association, interstep correction to
dissociation, and Savitzky–Golay filtering to result in the given
sensorgram. The respective values for kon, koff, and Kd were
determined by analyzing association and dissociation in a 1:1
model, full local fitting. For a confident determination of the
Kd, different concentrations of klotho were bound to either
biotinylated 3′-sialyllactose or biotindiol. The resulting binding
curves were processed and analyzed as described above, using
biotindiol at a given concentration of klotho as reference for
3′-sialyllactose with the same concentration of klotho. Equilibrium
response (Req) was plotted over concentration of klotho and the
Kd was determined using the following equation for the model
of site specific binding to one site: Req = (Rmax × concentration)/
(Kd + concentration).
Isolating of Cardiac Ventricular Myocytes from Mice with Induced
Hypertrophy. To induce cardiac hypertrophy, mice were admin-
istrated isoproterenol (3 mg/kg s.c.) daily for 15 d. Hypertrophied
hearts were removed, perfused retrograde via the aorta with a
solution containing (in millimolar) 113 NaCl, 4.7 KCl, 1.2MgSO4,
0.6 KH2PO4, 0.6 Na2HPO4, 10 NaHCO3, 30 taurine, 5.5 glucose,
10 2,3-butanedione monoxime, and 10 Hepes (at pH 7.4), fol-
lowed by a solution containing in addition 1 mg/mL type-2 col-
lagenase and 0.1 mg/mL protease XIV as described (9). The
perfusion solution was maintained at 37 °C and equilibrated with
100% O2. Thereafter, the ventricle was removed, chopped into
small pieces, and further digested in the enzyme solution. En-
zyme digestion was stopped by adding 2.5% (wt/vol) BSA and
0.1 mM CaCl2. The tissue–cell mixture was filtered through a
sterilized-gauze sponge, centrifuged using a tabletop centrifuge at
50 × g for 1 min. The resulting cell pellet was resuspended in the
stopping buffer and [Ca2+] titrated to 0.5 mM by addition of
100 mM CaCl2 stock solution in four steps over 20 min. Isolated
myocytes were stored at room temperature until use.
Electrophysiological Recordings of TRPC6 Currents. HEK293 cells
(control or expressing recombinant TRPC6) or freshly isolated
cardiac myocytes were voltage-clamped in ruptured whole-cell
mode with an Axopatch 200B patch-clamp amplifier and Pulse
software (Axon instruments Inc.) as previously described (9).
Cells were continuously perfused with bath solution. Cells were
held at 0-mV membrane potential (at −20 mV for recording
cardiac myocyte) and stimulated with repetitive ascending ramp
pulse from −100 mV to +100 mV for 400 ms every 10 s (or
descending from +80 mV to −100 mV for 500 ms every 10 s for
cardiac myocyte). The pipette and bath solution for recording
HEK293 cells contained (in millimolar) 140 CsCl, 1 MgCl2
1.5 CaCl2, 2 ATP-Mg, 5 EGTA, 10 Hepes (pH 7.2 with CsOH)
and 140 NaCl, 0.5 EGTA, 10 Hepes, 10 glucose, and 10 mannitol
(pH 7.4 with NaOH), respectively. The pipette and bath solution
for recording cardiac myocytes contained (in millimolar)
9.4 NaCl, 120 CsCl, 1 MgCl2 3.5 CaCl2, 0.2 GTP-Na, 10 BAPTA,
10 Hepes (pH 7.2 with CsOH) and 140 NaCl, 5 CsCl, 1 MgCl2,
10 glucose, and 10 Hepes (pH 7.4 with NaOH), respectively. For
recording cardiac myocytes, bath solution also contained 1 μM of
nifedipine and 3 mM of NiCl2 to block current flow through L-type
Ca2+ channel and Na+/Ca2+ exchanger, respectively. The resistance
of electrodes containing pipette solution was 1.5 ∼ 3 MΩ. TRPC6
currents were activated by bath application of 1-oleoyl-2-acetyl-sn-
glycerol (OAG, 100 μM), low-pass-filtered at 2 kHz, and sampled
every 0.1 ms (10 kHz). Data acquisition and analysis were per-
formed using pClamp9.2 program (Axon Instrument Inc.) and
Prism (V3.0) software (GraphPad Software).
GP Measurements. HEK293 cells were grown onto 35-mm glass-
bottom dishes (MatTek Corp.) to 70% confluency. Experimental
cells were shifted to phenol-free media (DMEM/F-12 media with
10% FBS, 15 mM Hepes, 2.5 mM L-glutamine, 100 U/mL pen-
icillin, and 100 U/mL streptomycin) 1 h before imaging. Di-4-
ANEPPDHQ (2 μM final concentration) was added to the media
and incubated for 5 min at 37 °C. When indicated, klotho was
added at the same time with di-4-ANEPPDHQ. Glucose oxidase
from Aspergillus niger (MP Biomedical), catalase from bovine
liver (Fisher), 200 U/mL glucose oxidase, and 0.04 mg/mL cat-
alase (1,404 U/mL) were added to the media right before im-
aging to reduce the phototoxic effect of the dye. Live-cell images
were obtained using Zeiss 780 laser-scanning confocal/multi-
photon-excitation fluorescence microscope with a 34-channel
GaAsP QUASAR detection unit and nondescanned detectors
for two-photon fluorescence (Zeiss). The imaging settings were
initially defined empirically to maximize the signal-to-noise ratio
and to avoid saturation, and they were kept constant for all
measurements for comparative imaging and results. Images
(focusing at the basal part of the cells, 5 s per image) were ac-
quired beginning at 5 min after incubation with di-4-ANEPPDHQ ±
klotho via a Zeiss C-Apochromat 40×/1.2 N.A. Korr FCS M27
water-immersion lens objective. The definite focus mechanism was
implemented to maintain the same focal plane over the whole
image acquisition period. One percent of a 30-mW Argon laser
was used for excitation at 488 nm, and emission signals corre-
sponding to the ordered and disordered phases were detected si-
multaneously through two spectral channels, Ch1 [508–588 nm
(ordered)] and Ch2 [615–695 nm (disordered)]. Image process-
ing was performed using Zeiss ZEN 2012 software. The series
of images were analyzed in ImageJ software. The two channels
were thresholded and made binary masks and then multiplied
by each corresponding channel to account for membranes only.
The thresholded Ch2 was then multiplied by a calibration factor,
G-factor. At each pixel, GP values were calculated using the
equation GP= I508−588 −GpI615−695=I508−588 +GpI615−695, where
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I508–588 and I615–695 are intensity values from the ordered
(Ch1) and disordered (Ch2) channels, respectively (22). The
G-factor was calculated from the formula G= I508−588pð1−
GPref .Þ=I615−695pð1−GPref .Þ, where GPref . is the GP value of the
di-4-ANEPPDHQ in a solution measured by the spectrofluo-
rometer, and I508–588 and I615–695 are the mean intensity values of
Ch1 and Ch2 images (taken from their corresponding histo-
grams) of the dye in a solution taken by the microscope using the
same microscope settings used while taking the time series im-
ages. The average G-factor value 1.106, determined from three
separate measurements) was used to calculate the mean GP
from the original raw data in this study. MeanGP values were set
to a range between −0.99 and 0.99.
FLIM-FRET Studies. HEK cells were stained (at room temperature
for 5 min) with BODIPY FL-505/510-C5-Ganglioside GM1
(donor, 100 nM) and with or without CholEsteryl BODIPY 542/
563-C11 (acceptor, 400 nM). Basic FLIM microscopy was done as
described above. For FLIM-FRET studies, a dichroic filter (488 nm,
Di02-R488-25-D; Semrock Inc.) was used to separate the fluo-
rescence signal, which was then detected by a 506- to 594-nm
(Semrock Inc.) emission filter that was placed in front of the
detector (GM1-cholesterol FLIM-FRET). A dichroic filter (594-nm,
Di02-R594-25-D; Semrock Inc.) was used to reflect the fluorescence
signal into a 506- to 594-nm (Semrock Inc.) filter that was placed
in front of the detector (GM1-klotho FLIM-FRET). The two-
photon excitation was blocked by a two-photon emission filter.
Images of the basolateral membrane were obtained in the 256 × 256
format with a pixel dwell time of 12.61 μs per pixel and averaging
over 30 frames. VistaVision software by ISS was used for the
acquisition and analysis of FLIM images. A digital-frequency-do-
main setup measured the modulation and phase at each pixel
within an image. For analysis using the phasor diagram, the
modulation (m) and phase (φ) determined the radial and angular
coordinate, respectively (12, 31). G and S values in the phasor plot
were calculated according to the following equations: G = m* cos
(φ); S = m* sin (φ). The phasor of the unquenched donor was
determined as the phasor of cells stained only with BODIPY-
GM1. The phasor of the background was determined as the
phasor of the autofluorescence signal from unstained cells. To
examine FRET occurrences, shifts of the donor–acceptor vs. do-
nor only phasors were determined. The trajectory of variable
FRET efficiencies was drawn in the plot. The position that donor
was quenched in the presence of acceptor yields the value of ef-
ficiency associated with the FRET interaction.
MEND. MEND responses in HEK293 cells were determined as
described (27). Klotho (1 nM) was applied to cells after removal
from culture dishes. Upon dispersion into the recording chamber
the klotho concentration was decreased to 0.1 nM.
Statistical Analysis. Each experiment was repeated at least once
with similar results. Data are presented as mean ± SEM. Sta-
tistical comparison between two groups of data were made using
two-tailed unpaired Student’s t test. Multiple comparisons were
determined using one-way analysis of variance followed by
Tukey’s multiple comparison tests.
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Fig. S1. (A–D) Representative images and Pearson’s coefficient showing colocalization of CTxB/Cav-1, no colocalization for CTxB/CD71, and effect of MβCD or
sKL treatment on CTxB/BODIPY-GM1 colocalization. Note that fluorescence intensity of CTxB-Alexa Fluor 594 in cells treated with sKL is reduced by ∼11%
compared with without klotho treatment, due to the fact that sKL binds sialic acids of gangliosides and competes for CTxB binding (Fig. 3 and Fig. S6). The mild
reduction in CTxB-labeled fluorescence intensity does not affect Pearson’s correlation coefficient because the analysis is based on correlation between green
and red channel pixel intensity histogram and is independent of absolute fluorescence intensity. (Scale bars, 5 μm.)
Dalton et al. www.pnas.org/cgi/content/short/1620301114 4 of 9
Fig. S2. Klotho decreases membrane order analyzed by using a polarity-sensitive membrane probe. (A) Cells were incubated with ANEPPDHQ (2 μM) ± klotho
(300 pM) for 5 min at 37 °C before imaging (5 s per image consecutively for total 300 images over the subsequent 25 min). Line plots show mean GP values for
300 single images over time. Heat-inactivated klotho (70 °C for 10 min) had no effects on GP values. (B) GP was calculated by ratiometric measurement of the
fluorescence intensity recorded in two spectral channels using the equation shown. (Scale bars, 20 μm.) (C) Bar graph shows reversibility of GP (taken at 30 min)
after washout of sKL.
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Fig. S3. Effect of sKL and Wmn on growth factor-driven PI3K/Akt signaling. (A and B) HeLa cells grown in serum-containing medium were serum-starved for
24 h, pretreated with sKL or vehicle, and stimulated by IGF1 (26 nM) for 5 min. A shows one representative experiment. B shows mean ± SEM from 3 separate
experiments. *P < 0.05 between indicated groups. (C and D) PI3K inhibitor Wmn (100 nM for 2 h) abrogates PI3K/Akt signaling in lipid rafts (fractions 4 and 5)
and nonraft membrane (fractions 9–12). Confluent HeLa cells grown in serum-containing medium were treated with vehicle or Wmn before lysis in an ice-cold
detergent lysis buffer containing 1% Triton X-100 and subjected to sucrose gradient ultracentrifugation. pT-Akt, phosphorylation of Akt at Thr-308; pS-Akt, at
Ser-473. T-Akt indicates total Akt. A shows one representative experiment. B shows mean ± SEM from four separate experiments. *P < 0.01, vehicle vs. Wmn.
The inverted triangle indicates bar height not visible. Note that virtually all cellular proteins including cytosolic proteins and Triton X-100–soluble plasma
membrane and inner organelle proteins are distributed in the nonraft regions. Because nonraft membranes include the bulk of cell membranes and in-
tracellular organelles, the total abundance of proteins in nonraft membrane fractions is >300-fold higher than in raft regions. This fact explains why the
unnormalized abundance of Akt (not normalized to protein density) in nonraft regions is approximately fivefold more than in raft regions (see quantitation in
Fig. 2B). In our studies, we presented unnormalized results given that normalized Akt signals are below detection.
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Fig. S4. Evidence for important role of raft-associated PI3K signaling in DAG-stimulated TRPC6 channel activity. (A) Time course of DAG-stimulated currents.
Confluent cells expressing TRPC6 channels were either serum-starved for 24 h or not starved and incubated with or without filipin (10 μg/mL for 1 h) or Wmn
(200 nM for 30 min) before recording. Ruptured whole-cell TRPC6 currents in response to repetitive ascending voltage ramp (−100 mV to +100 mV for 400 ms
every 10 s) were recorded. After 2–3 min, OAG, a membrane-permeant analog of DAG (100 μM), was added to the bath solution to activate TRPC6 currents.
Basal currents before addition of OAG were not significantly different from untransfected cells. At the end of experiments, the bath solution was replaced by a
solution containing nonpermeant cation N-methyl-D-glucamine (NMDG) to assess TRPC6-mediated inward currents. Circles and error bars represent mean ±
SEM (n = 7–14 cells recorded for each group). (B) Representative current–voltage relationship curves of peak currents. (C) DAG-stimulated inward TRPC6
current density shows no additivity between inhibition of TRPC6 by filipin, Wmn, or serum-deprivation, indicating that DAG stimulation of TRPC6 channel
activity requires a cholesterol-dependent, serum-stimulated PI3K signaling pathway. NS, not significant.
Fig. S5. Reversibility of klotho inhibition of TRPC6 after klotho washout. (A) Cells expressing TRPC6 were treated with or without sKL (300 pM) in serum
medium overnight. Cells were washed three times using PBS to remove klotho. Cells were recorded for DAG-stimulated TRPC6 currents immediately after
washout (0 h) or incubated in serum-free medium + IGF1 (13 nM) at 37 °C for 1 h or 3 h before recording. Data are mean ± SEM of inward TRPC6 current density
(n = 8–12 cells recorded for each group). *P < 0.01 between indicated groups. #P < 0.05 between indicated groups. After klotho washout, the 1- to 3-h delay in
the recovery of DAG-stimulated TRPC6 currents back to the level without klotho treatment is probably due to the time required for lipid rafts to reform, for
PI3K/Akt to reassociate with rafts, and for PI3K/Akt signaling to prime TRPC6 vesicles for stimulated exocytosis by DAG. Note that whereas sKL affects lipid rafts
in 5–10 min (Fig. 1), given the mechanism for PI3K to regulate TRPC6 exocytosis is unknown and that it will take time for PI3K’s effect to subside after inhibition
by klotho, we treated cells with sKL for 3 h before recording of TRPC6. Inhibition of TRPC6 is reversible upon klotho washout, which supports the notion that
the effect is not mediated by uptake and intracellular action of klotho. NS, not significant. (B) Time course of DAG-stimulated currents. (C) Current–voltage
relationship curves of peak TRPC6 currents.
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Fig. S6. Structural determinants of GM1 and GM3 for klotho binding and inhibition of lipid raft-associated PI3K/Akt signaling and TRPC6 channel activity.
(A) sKL (300 pM final concentration) was mixed with GM1 or asialo-GM1 (17 μM final concentration) in 1 mL cell culture medium for 1 h. Cells were incubated
with the mixture medium at 37 °C for 3 h before recording. In control experiments, medium contains no sKL with or without GM1 or asialo-GM1. n = 10–14
each group. *P < 0.01 between indicated groups. (B) Experiments as in A except that GM3 or LacCer was used. n = 11–13 each group. *P < 0.01 between
indicated groups. (C) Experiments as in A except that GM3 or GD3 was used. n = 15–17 each group. *P < 0.01 between indicated groups. (D) Experiments as in
A except that 3′-sialyllactose (3′-SiaLac) or lactose (Lac) was used. n = 13–16 each group. *P < 0.01 between indicated groups. (E) Dose–response curve
for competition of klotho’s effect by GM3. Apparent Kd for GM3 estimated at 3 μM. (F) Dose–response curve for competition of klotho’s effect by α2-3-
sialyllactose. Apparent Kd for free α2-3-sialyllactose estimated at 1 mM. (G) Spectral shifts of reflected light due to changes in biosensor thickness (Δλ, in
nanometers) were measured following 170 nM klotho binding to streptavidin sensors loaded with 150 nM biotin-labeled α2-3-sialyllactose, lactose, or only
biotin against biotindiol reference. One of two experiments is shown. (H) Steady-state maximal binding at different concentrations of klotho was performed.
Equilibrium binding constant (Kd) calculated from dose–response studies assuming one specific binding site is 39.9 ± 12.6 nM (mean ± SEM; n = 14 individual
data points) and agrees with the Kd value calculated based on the ratio of off-rate constant (koff) over on-rate constant (kon). NS, not significant.
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Fig. S7. Dose–response curve for competition of klotho’s effect by α2-6-sialyllactose. (A) Cells expressing TRPC6 were treated with sKL (300 pM final con-
centration) premixed with α2-6-sialyllactose (6′-SiaLac) at different concentrations. In control experiments, medium contains no sKL. Data are mean ± SEM of
inward TRPC6 current density (n = 10–13 cells recorded for each group). *P < 0.01 vs. no sKL. (B) Time course of DAG-stimulated currents. (C) Current–voltage
relationship curves of peak TRPC6 currents.
Fig. S8. Klotho blunts MEND (massive endocytosis) of surface membrane but does not cause global membrane disorder. (A) Representative record of MEND.
Membrane capacitance, a measurement of cell membrane area (blue trace, in picofarads), and membrane current (red trace, in nanoamperes) were measured
by patch-clamp recording. After Ca2+ influx was activated by applying 2 mM external Ca2+ for 10 s in the presence of 40 mM cytoplasmic Na+, MEND amounted
to more than 40% of the surface membrane. (B) Incubation of cells with klotho decreased MEND by more than 60%. Depletion of ceramide-dependent
gangliosides by NB-DGJ (25 μM, overnight) did not decrease MEND but ablated the ability of klotho to inhibit MEND. Data represent mean ± SEM *P < 0.05,
* *P < 0.01 between indicated groups. (C) Representative record of hexyltriphenylphosphonium (C6TPP) permeation experiments. Membrane capacitance (red
trace, in picofarads) and inward current (blue trace, in picoamperes) were measured by patch-clamp recording. Extracellular applications of C6TPP generated
reversible inward currents. (D) Klotho treatment does not affect C6TPP-dependent inward currents.
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